bioRxivPharmacology & Toxicology
Tales of 1,008 Small Molecules: Phenomic Profiling through Live-cell Imaging in a Panel of Reporter Cell Lines
M. J. Cox, S. Jaensch, J. Van de Waeter, L. Cougnaud, D. Seynaeve, S. Benalla, S. J. Koo, I. Van Den Wyngaert, J.-M. Neefs, D. Malkov, M. Bittremieux, M. Steemans, P. J. Peeters, J. K. Wegner, H. Ceulemans, E. Gustin, Y. T. Chong, H. W. H. Göhlmann
Abstract
Phenomic profiles are high-dimensional sets of readouts that can comprehensively capture the biological impact of chemical and genetic perturbations in cellular assay systems. Phenomic profiling of compound libraries can be used for compound target identification or mechanism of action (MoA) prediction and other applications in drug discovery. To devise an economical set of phenomic profiling assays, we assembled a library of 1,008 approved drugs and well-characterized tool compounds manually annotated to 218 unique MoAs, and we profiled each compound at four concentrations in live-cell, high-content imaging screens against a panel of 15 reporter cell lines, which expressed a diverse set of fluorescent organelle and pathway markers in three distinct cell lineages. For 41 of 83 testable MoAs, phenomic profiles accurately ranked the reference compounds (AUC-ROC [≥]0.9). MoAs could be better resolved by screening compounds at multiple concentrations than by including replicates at a single concentration. Screening additional cell lineages and fluorescent markers increased the number of distinguishable MoAs but this effect quickly plateaued. There remains a substantial number of MoAs that were hard to distinguish from others under the current studys conditions. We discuss ways to close this gap, which will inform the design of future phenomic profiling efforts.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selection of optimal cell lines for high-content phenotypic screening
L. Heinrich, K. Kumbier, … L. Wu·bioRxiv·Jan 11, 2023
- Morphological Profiling Dataset of EU-OPENSCREEN Bioactive Compounds Over Multiple Imaging Sites and Cell Lines
Christopher Wolff, Martin Neuenschwander, … Christopher Schmied·iSciencePeer-reviewed·Apr 17, 2025
- Evaluation of gene expression and phenotypic profiling data as quantitative descriptors for predicting drug targets and mechanisms of action
Maris Lapins, Ola Spjuth·bioRxiv·Jul 3, 2019
- Cell Painting PLUS expands morphological profiling to enhance mechanistic understanding of compounds
Marlene Wedler, José M. Muiño, … Shu Liu·bioRxiv·Oct 20, 2026
- Confounder-aware foundation modeling for accurate phenotype profiling in cell imaging
Giorgos Papanastasiou, Pedro P. Sanchez, … Walter Hugo Lopez Pinaya·npj ImagingPeer-reviewed·Oct 22, 2025
- Cell Painting in activated cells illuminates phenotypic dark space and uncovers novel drug mechanisms of action.
Matylda Zietek, Akshar Lohith, … R. Scott Lokey·bioRxiv·May 23, 2025